Tag Archives: U.S.

AbbVie touts Humira defense strategy abroad as a positive sign for forthcoming U.S. battle

AbbVie’s strength has long been tied to the performance of megablockbuster Humira, which is facing an existential threat as U.S. copycats creep closer. Despite a “more aggressive” than expected biosimilar challenge abroad, AbbVie believes its defense strategy—and lessons learned—will help it weather the storm. In an earnings call with analysts Friday, AbbVie CEO Rick Gonzalez touted the drugmaker’s… Read More »

A stunning indictment of the U.S. health-care system, in one chart – The Washington Post

The report also shows a growing income gap in cost-related delays. In 2016, for instance, one-fourth of U.S. households earning less than $ 40,000 a year reported cost-related delays, vs. 13 percent for households making more than $ 100,000. In 2019, the rate of cost-related delays among poorer households shot up to 36 percent, while… Read More »

Can psychedelics treat anorexia, depression? U.S. scientists get millions to find out

Since childhood, Rachael Petersen had lived with an unexplainable sense of grief that no drug or talk therapy could entirely ease. So in 2017 she volunteered for a small clinical trial at Johns Hopkins University that was testing psilocybin, the active ingredient in magic mushrooms, for chronic depression. “I was so depressed,” Petersen, 29, said… Read More »

Health Canada warns against modifying vape pens amid two deaths, spreading illness in U.S.

Health Canada says people who vape should get medical attention right away if they’re worried their electronic cigarettes are harming them. The federal department says there is no sign in Canada of an affliction reported in as many as 25 American states that seems to be linked to vaping, but it is monitoring the situation.… Read More »